GAO finding of PPI drug price inflation overstatement is not "compelling," BLS commissioner maintains.
GAO FINDING OF DRUG PRICE INFLATION OVERSTATEMENT IS NOT "COMPELLING," BLS Commissioner Katherine Abraham told the General Accounting Office in comments on GAO's draft report "Prescription Drug Prices: Official Index Overstates Inflation." The report contends that the Bureau of Labor Statistics' producer price index for prescription drugs "substantially" overstated the inflation rate for drugs between 1984-91. Requested by Senate Special Aging Committee Chairman Cohen (R-Maine), the GAO report was released May 30.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth